A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)
A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)
Active, not recruiting · NCT07225959 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07) | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 2 | 2026-08-20 | NCT07225959 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Floridian Clinical Research | Miami Lakes | United States | 16 |
| Floridian Clinical Research ( Site 0102) | Miami Lakes | United States | 1 |
| hVIVO ( Site 0001) | London | United Kingdom | 1 |
| hVIVO Serviced Limited | London | United Kingdom | 1 |
| Spartanburg Medical Research | Spartanburg | United States | 13 |
| Spartanburg Medical Research ( Site 0101) | Spartanburg | United States | 1 |